Molecular profiling - a tool for addressing emerging gaps in the comparative risk assessment of GMOs

被引:35
作者
Heinemann, Jack A. [1 ,2 ]
Kurenbach, Brigitta [1 ,2 ]
Quist, David [2 ]
机构
[1] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand
[2] GenOk Ctr Biosafety, Tromso, Norway
关键词
Genomics; Transcriptomics; Proteomics; Metabolomics; Epigenomics; Genetically modified organisms; Risk assessment; 2-DIMENSIONAL GEL-ELECTROPHORESIS; GENETICALLY-MODIFIED CROPS; INTERROGATE ALTERATIONS; NATURAL VARIABILITY; CEREBROSPINAL-FLUID; SAFETY ASSESSMENT; TRANSGENIC RICE; PRION PROTEIN; GENE; TRANSCRIPTOME;
D O I
10.1016/j.envint.2011.05.006
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Assessing the risks of genetically modified organisms (GMOs) is required by both international agreement and domestic legislation. Many view the use of the "omics" tools for profiling classes of molecules as useful in risk assessment, but no consensus has formed on the need or value of these techniques for assessing the risks of all GMOs. In this and many other cases, experts support case-by-case use of molecular profiling techniques for risk assessment. We review the latest research on the applicability and usefulness of molecular profiling techniques for GMO risk assessment. As more and more kinds of GMOs and traits are developed, broader use of molecular profiling in a risk assessment may be required to supplement the comparative approach to risk assessment. The literature-based discussions on the use of profiling appear to have settled on two findings: 1. profiling techniques are reliable and relevant, at least no less so than other techniques used in risk assessment: and 2. although not required routinely, regulators should be aware of when they are needed. The dismissal of routine molecular profiling may be confusing to regulators who then lack guidance on when molecular profiling might be worthwhile. Molecular profiling is an important way to increase confidence in risk assessments if the profiles are properly designed to address relevant risks and are applied at the correct stage of the assessment. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1285 / 1293
页数:9
相关论文
共 82 条
[1]  
AHTEG, 2010, GUID DOC RISK ASS LI
[2]   Understanding the mismatch between the demands of risk assessment and practice of scientists - The case of Deca-BDE [J].
Alcock, Ruth E. ;
MacGillivray, Brian H. ;
Busby, Jerry S. .
ENVIRONMENT INTERNATIONAL, 2011, 37 (01) :216-225
[3]   Proteomic profiling of recombinant Escherichia coli in high-cell-density fermentations for improved production of an antibody fragment biopharmaceutical [J].
Aldor, IS ;
Krawitz, DC ;
Forrest, W ;
Chen, C ;
Nishihara, JC ;
Joly, JC ;
Champion, KM .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2005, 71 (04) :1717-1728
[4]   RNAi-mediated replacement of morphine with the nonnarcotic alkaloid reticuline in opium poppy [J].
Allen, RS ;
Millgate, AG ;
Chitty, JA ;
Thisleton, J ;
Miller, JAC ;
Fist, AJ ;
Gerlach, WL ;
Larkin, PJ .
NATURE BIOTECHNOLOGY, 2004, 22 (12) :1559-1566
[5]   Assessing environmental risks of transgenic plants [J].
Andow, DA ;
Zwahlen, C .
ECOLOGY LETTERS, 2006, 9 (02) :196-214
[6]  
[Anonymous], 2009, DO SEED COMPANIES CO
[7]  
[Anonymous], 2005, Modern food biotechnology, human health and development: An evidence-based study
[8]  
*AUSTR COMP AUTH, 2009, FOOD FEED IMP PROC 9
[9]  
Barros E., 2010, MOL PROFILING TECHNI
[10]   Comparison of two GM maize varieties with a near-isogenic non-GM variety using transcriptomics, proteomics and metabolomics [J].
Barros, Eugenia ;
Lezar, Sabine ;
Anttonen, Mikko J. ;
van Dijk, Jeroen P. ;
Roehlig, Richard M. ;
Kok, Esther J. ;
Engel, Karl-Heinz .
PLANT BIOTECHNOLOGY JOURNAL, 2010, 8 (04) :436-451